Patients with pleural effusion | Pulmonary carcinoma (n = 110) | Pneumonia (n = 13) | Tuberculosis (n = 42) | Heart failure/hypoproteinemia(n = 38) | Extrapulmonary carcinoma (n = 6) | |
---|---|---|---|---|---|---|
Malignant (n = 106) | Nonmalignant (n = 4) | |||||
Age ( ± S) | 63.35 ± 9.35 | 61.25 ± 6.29 | 46.23 ± 11.56 | 43.38 ± 13.88 | 64.78 ± 8.53 | 51.17 ± 9.13 |
Sex (M/F) | 55/51 | 2/2 | 7/6 | 20/22 | 20/18 | 2/4 |
Cast-off (N/P) | 38/68 | 4/0 | 13/0 | 42/0 | 38/0 | 3/3 |
Pleural biopsy (n) | 49 | 4 | — | 8 | — | 3 |
TNM stage | Â | Â | Â | Â | Â | Â |
I | — | 3 | — | — | — | 1 |
II | — | 1 | — | — | — | 1 |
III | — | — | — | — | — | — |
IV | 106 | — | — |  | — | 4 |
Pathological type | Â | Â | Â | Â | Â | Â |
 | SCC 26 | — | — | — | — | Hepatoma 2 |
 | Ade 71 | — | — | — | — | ovarian cancer 1 |
 | SCLC 9 | — | — | — | — | pleural endotheliomas 1 |
 |  |  | — | — | — | breast cancer 2 |
Pleural effusion ( ± S) |  |  |  |  |  |  |
PH | 7.42 ± 0.05 | 7.45 ± 0.02 | 7.18 ± 0.04 | 7.36 ± 0.04 | 7.45 ± 0.05 | 7.48 ± 0.03 |
LDH | 665.48 ± 226.18 | 203.25 ± 57.64 | 363.46 ± 64.7 | 384.93 ± 93.44 | 135.79 ± 32.38 | 575.5 ± 152.28 |
Glu | 4.52 ± 0.81 | 4.87 ± 0.3 | 4.78 ± 0.53 | 4.7 ± 0.58 | 4.74 ± 0.36 | 4.46 ± 0.77 |
Alb | 46.59 ± 4.84 | 24.11 ± 1.57 | 42.47 ± 5.05 | 47.57 ± 4.59 | 22.15 ± 2.28 | 47.93 ± 4.63 |